193 related articles for article (PubMed ID: 1027719)
1. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
Tamura N; Baba AS
Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
[TBL] [Abstract][Full Text] [Related]
2. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
Hammer CH; Abramovitz AS; Mayer MM
J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
[TBL] [Abstract][Full Text] [Related]
3. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.
Yamamoto KI; Lint TF; Gewurz H
J Immunol; 1977 Oct; 119(4):1346-50. PubMed ID: 894040
[TBL] [Abstract][Full Text] [Related]
5. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
[TBL] [Abstract][Full Text] [Related]
6. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
7. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
McLeod B; Baker P; Behrends C; Gewurz H
Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
[TBL] [Abstract][Full Text] [Related]
8. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
Kitamura H; Tsuboi M; Nagaki K
Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
[TBL] [Abstract][Full Text] [Related]
9. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
[TBL] [Abstract][Full Text] [Related]
10. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
[TBL] [Abstract][Full Text] [Related]
11. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
Miyama A; Kato T; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
13. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
14. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
Okada H; Okada N
Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
[TBL] [Abstract][Full Text] [Related]
15. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
Yamamoto KI
J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
[TBL] [Abstract][Full Text] [Related]
16. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
17. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
Hänsch G; Rother U; Rother K
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
[TBL] [Abstract][Full Text] [Related]
18. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
Nemerow GR; Gewurz H; Osofsky SG; Lint TF
J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.
Baker PJ; Lint TF; Siegel J; Kies MW; Gewurz H
Immunology; 1976 Apr; 30(4):467-73. PubMed ID: 818007
[TBL] [Abstract][Full Text] [Related]
20. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
